Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Changed?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has started to gain momentum again and is beginning to erase some of the losses…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Another Day, Another Controversy

    | Benjamin Sinclair

    The trouble continues for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Stocks for Beginners

    Why New Investors Should Stop Hoping for Quick Gains

    | Kay Ng

    Using Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as an example, I illustrate why new investors should stop using volatile stocks for…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: If You Believe Management, it’s a Screaming Buy

    | Nelson Smith

    Most Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) bears say investors can't trust the company's management. But what if they're wrong and…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: the 3 Biggest Takeaways From its Latest Conference Call

    | Benjamin Sinclair

    Vealeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues its damage-control efforts.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Why its Pricing Strategy Is Immoral and Unsustainable

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) uses backdoor tactics to overcharge for its products.

    Read more »

    The Motley Fool
    Investing

    Why Are Shares of Valeant Pharmaceuticals Intl Inc. Plunging This Time?

    | Benjamin Sinclair

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are once again in free fall. What's going on this time?

    Read more »

    The Motley Fool
    Investing

    The 3 Biggest Threats Facing Valeant Pharmaceuticals Intl Inc.

    | Benjamin Sinclair

    Think the troubles for Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are over? Think again.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Has Lost $100 Billion in Value Since August. Is it Going to $0?

    | Ryan Vanzo

    With nearly no clarity into the company’s startling allegations, it’s tough to recommend that anyone should own Valeant Pharmaceuticals Intl…

    Read more »

    The Motley Fool
    Investing

    Why Bill Ackman Thinks Valeant Pharmaceuticals Intl Inc. Will Quadruple in 3 Years

    | Benjamin Sinclair

    Bill Ackman thinks that Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is wildly misunderstood. Is he right?

    Read more »

    The Motley Fool
    Investing

    Don’t Be Fooled by Valeant Pharmaceuticals Intl Inc.

    | Nelson Smith

    Value investors are starting to sniff around Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Here's why it could be the ultimate value…

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Has No Friends

    | Benjamin Sinclair

    Nobody likes Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), and that could spell big trouble for the company.

    Read more »